These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
250 related items for PubMed ID: 15728993
1. In vitro susceptibility of Candida species isolated from blood culture to some antifungal agents. Citak S, Ozçelik B, Cesur S, Abbasoğlu U. Jpn J Infect Dis; 2005 Feb; 58(1):44-6. PubMed ID: 15728993 [Abstract] [Full Text] [Related]
2. [Comparison of broth microdilution and E-test methods for the antifungal susceptibility testing of Candida spp. strains isolated from blood cultures]. Ozcan SK, Mutlu B, Dündar D, Willke A. Mikrobiyol Bul; 2010 Apr; 44(2):263-71. PubMed ID: 20549961 [Abstract] [Full Text] [Related]
5. [Antifungal susceptibility of Candida spp. isolates from blood cultures in a five-year period (1997-2001)]. Durán MT, Velasco D, Canle D, Moure R, Villanueva R. Enferm Infecc Microbiol Clin; 2003 Nov; 21(9):488-92. PubMed ID: 14572381 [Abstract] [Full Text] [Related]
6. Candidemia and the susceptibility pattern of Candida isolates in blood. Osoba AO, Al-Mowallad AW, McAlear DE, Hussein BA. Saudi Med J; 2003 Oct; 24(10):1060-3. PubMed ID: 14578968 [Abstract] [Full Text] [Related]
7. Epidemiology and antifungal susceptibilities of Candida spp. to six antifungal agents: results from a surveillance study on fungaemia in Germany from July 2004 to August 2005. Borg-von Zepelin M, Kunz L, Rüchel R, Reichard U, Weig M, Gross U. J Antimicrob Chemother; 2007 Aug; 60(2):424-8. PubMed ID: 17562683 [Abstract] [Full Text] [Related]
9. Activities of micafungin against 315 invasive clinical isolates of fluconazole-resistant Candida spp. Messer SA, Diekema DJ, Boyken L, Tendolkar S, Hollis RJ, Pfaller MA. J Clin Microbiol; 2006 Feb; 44(2):324-6. PubMed ID: 16455878 [Abstract] [Full Text] [Related]
10. Antifungal susceptibility of Candida spp. isolated from pediatric patients: a survey of 4 children's hospitals. Zaoutis TE, Foraker E, McGowan KL, Mortensen J, Campos J, Walsh TJ, Klein JD. Diagn Microbiol Infect Dis; 2005 Aug; 52(4):295-8. PubMed ID: 15922535 [Abstract] [Full Text] [Related]
11. Candida albicans versus non-albicans bloodstream infection in patients in a tertiary hospital: an analysis of microbiological data. Samonis G, Kofteridis DP, Saloustros E, Giannopoulou KP, Ntziora F, Christidou A, Maraki S, Falagas ME. Scand J Infect Dis; 2008 Aug; 40(5):414-9. PubMed ID: 18418802 [Abstract] [Full Text] [Related]
12. In vitro susceptibility of Candida species isolated from cancer patients to some antifungal agents. Ozçelik B, Citak S, Cesur S, Abbasoğlu U, Içli F. Drug Metabol Drug Interact; 2004 Aug; 20(1-2):101-8. PubMed ID: 15283306 [Abstract] [Full Text] [Related]
13. CHROMagar Candida medium for direct susceptibility testing of yeast from blood cultures. Tan GL, Peterson EM. J Clin Microbiol; 2005 Apr; 43(4):1727-31. PubMed ID: 15814992 [Abstract] [Full Text] [Related]
14. Candida haemulonii and closely related species at 5 university hospitals in Korea: identification, antifungal susceptibility, and clinical features. Kim MN, Shin JH, Sung H, Lee K, Kim EC, Ryoo N, Lee JS, Jung SI, Park KH, Kee SJ, Kim SH, Shin MG, Suh SP, Ryang DW. Clin Infect Dis; 2009 Mar 15; 48(6):e57-61. PubMed ID: 19193113 [Abstract] [Full Text] [Related]
20. Emergence of non-albicans Candida species and antifungal resistance in a tertiary care hospital. Capoor MR, Nair D, Deb M, Verma PK, Srivastava L, Aggarwal P. Jpn J Infect Dis; 2005 Dec 15; 58(6):344-8. PubMed ID: 16377864 [Abstract] [Full Text] [Related] Page: [Next] [New Search]